STIM:NASDAQ
Neuronetics Inc
$2.76
0.00%
(0.00) 1D
$2.79
arrow_upward
+1.11% (+0.031)todayPre-market
Closed: Sep 16, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for STIM...
Mkt. cap
210.30M
Avg. vol.
2.53M
Volume
1.17K
52-wk high
$3.44
52-wk low
$0.80
EPS
-$0.44
Beta
1.16
Shares outstanding
76.20M
No. of employees
658
Mkt. cap
210.30M
Avg. vol.
2.53M
Volume
1.17K
52-wk high
$3.44
52-wk low
$0.80
EPS
-$0.44
Beta
1.16
Shares outstanding
76.20M
No. of employees
658
Profile
Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology.
Neuronetics became the "first and only Food and Drug Administration approval for the clinical treatment of a specific form of medication-refractory depression using a TMS Therapy device."
They manufacture a transcranial magnetic stimulation device, NeuroStar. The NeuroStar TMS therapy is delivered via a precisely positioned magnetic coil against the patient's head. Wikipedia
About Neuronetics Inc
CEO-
Employees658
Founded2003
HeadquartersMalvern, Pennsylvania, United States
SectorMedical device
Websiteneurostar.com